<DOC>
	<DOC>NCT00438412</DOC>
	<brief_summary>The mechanisms involved in development and maintenance of hypertension in obstructive sleep apnea are not clarified. We hypothesize that patients with obstructive sleep apnea have an abnormal level of some vasoactive hormones during apneic events during sleep.</brief_summary>
	<brief_title>Vasoactive Hormones and Oxygen Saturation During Apneic Events in Patients With Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea, Obstructive</mesh_term>
	<criteria>Patients with Obstructive sleep apnea Severe obstructive sleep apnea (apneahypopnea index &gt; 30) Drug or alcohol abuse Pregnancy History or clinical signs of disease in the heart, lungs, brain, liver, kidneys or endocrine organs Diabetes Healthy Controls Apneahypopnea index &lt; 10 Exclusion criteria: Drug or alcohol abuse Pregnancy History or clinical signs of disease in the heart, lungs, brain, liver, kidneys or endocrine organs Diabetes</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Noradrenalin</keyword>
	<keyword>Endothelin-1</keyword>
	<keyword>Angiotensin II</keyword>
	<keyword>Arginine vasopressin</keyword>
	<keyword>Aldosterone</keyword>
	<keyword>Renin</keyword>
	<keyword>Atrial natriuretic peptide</keyword>
	<keyword>Brain natriuretic peptide</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Apnea</keyword>
</DOC>